1. Home
  2. TIL vs PED Comparison

TIL vs PED Comparison

Compare TIL & PED Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TIL
  • PED
  • Stock Information
  • Founded
  • TIL 2018
  • PED N/A
  • Country
  • TIL United States
  • PED United States
  • Employees
  • TIL N/A
  • PED N/A
  • Industry
  • TIL Biotechnology: Pharmaceutical Preparations
  • PED Oil & Gas Production
  • Sector
  • TIL Health Care
  • PED Energy
  • Exchange
  • TIL Nasdaq
  • PED Nasdaq
  • Market Cap
  • TIL 230.1M
  • PED 48.8M
  • IPO Year
  • TIL 2021
  • PED N/A
  • Fundamental
  • Price
  • TIL $24.49
  • PED $0.64
  • Analyst Decision
  • TIL Buy
  • PED Strong Buy
  • Analyst Count
  • TIL 5
  • PED 2
  • Target Price
  • TIL $119.00
  • PED $1.63
  • AVG Volume (30 Days)
  • TIL 310.3K
  • PED 584.5K
  • Earning Date
  • TIL 08-12-2025
  • PED 08-13-2025
  • Dividend Yield
  • TIL N/A
  • PED N/A
  • EPS Growth
  • TIL N/A
  • PED 2248.88
  • EPS
  • TIL N/A
  • PED 0.19
  • Revenue
  • TIL N/A
  • PED $40,173,000.00
  • Revenue This Year
  • TIL N/A
  • PED N/A
  • Revenue Next Year
  • TIL N/A
  • PED $5.99
  • P/E Ratio
  • TIL N/A
  • PED $3.31
  • Revenue Growth
  • TIL N/A
  • PED 30.70
  • 52 Week Low
  • TIL $9.70
  • PED $0.47
  • 52 Week High
  • TIL $92.00
  • PED $1.10
  • Technical
  • Relative Strength Index (RSI)
  • TIL 47.69
  • PED 44.12
  • Support Level
  • TIL $21.80
  • PED $0.58
  • Resistance Level
  • TIL $26.91
  • PED $0.64
  • Average True Range (ATR)
  • TIL 3.52
  • PED 0.04
  • MACD
  • TIL -0.37
  • PED -0.01
  • Stochastic Oscillator
  • TIL 35.14
  • PED 21.28

About TIL Instil Bio Inc.

Instil Bio Inc is a clinical-stage biopharmaceutical company focused on developing a cell therapy pipeline of autologous tumor infiltrating lymphocyte, or TIL, therapies for the treatment of patients with cancer. It is also engaged in developing a novel class of genetically engineered TIL therapies using its Co-Stimulatory Antigen Receptor, or CoStAR, platform. Its pipeline includes ITIL-306 which expresses a CoStAR molecule designed to recognize, a tumor-associated antigen that is expressed on numerous solid tumors, including ovarian cancer, uterine cancer, NSCLC, and renal cancer.

About PED Pedevco Corp.

PEDEVCO Corp is an oil and gas company focused on oil and natural gas development, exploration, and production. The company focuses on legacy properties where there is a long production history, well-defined geology and existing infrastructure that can be leveraged when applying modern field management technologies. The current properties of the company are located in the San Andres formation of the Permian Basin, situated in West Texas and eastern New Mexico (the Permian Basin), and in the Denver-Julesberg Basin (D-J Basin) in Colorado and Wyoming.

Share on Social Networks: